Dr. Matthew Frigault, MD

• Medical Oncology

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Pennsylvania Perelman School Of Medicine

  Medical School, 2012

• Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma, 2022-11-01

• Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors, 2022-03-18

• CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma, 2019-11-14

• Acute Kidney Injury and Electrolyte Abnormalities After Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Diffuse Large B-Cell Lymphoma, 2020-01-20

• Non-cleavable hinge enhances avidity and expansion of CAR-T cells for acute myeloid leukemia, 2022-04-21

• Distinct cellular dynamics associated with response to CAR-T therapy for refractory B-cell lymphoma, 2022-09-12

• CARs in the lead against Multiple Myeloma, 2017-03-17

• Chimeric antigen receptor T cells targeting CD79b show efficacy in lymphoma with or without co-targeting CD19, 2019-08-22

• Immune Checkpoint Inhibitors for Cancer and Venous Thromboembolic Events, 2021-10-15

• CAR-Based Approaches to Cutaneous T-Cell Lymphoma, 2019-04-16

• Cardiovascular Events Among Adults Treated with Chimeric Antigen Receptor T-Cells (CAR-T), 2019-12-24